查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
吸入器和鼻腔喷雾仿製药市场规模、份额和趋势分析报告：按药物类别、适应症、患者细分、最终用户、分销渠道、地区、细分市场预测，2022-2030
市场调查报告书
商品编码
1122262

吸入器和鼻腔喷雾仿製药市场规模、份额和趋势分析报告：按药物类别、适应症、患者细分、最终用户、分销渠道、地区、细分市场预测，2022-2030

Inhalation And Nasal Spray Generic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Indication, By Patient Demographics, By End-user, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10个工作天内

价格

吸入器和鼻喷雾仿製药市场增长和趋势

根据 Grandview Research 的一份新报告，到 2030 年，全球仿製药吸入器和鼻喷雾剂市场预计将达到 384 亿美元。从 2022 年到 2030 年，市场预计将以 8.96% 的复合年增长率增长。新产品的推出、慢性呼吸道疾病的流行、对具有成本效益的药品的需求不断增加以及老年人口的增加是推动市场增长的主要因素。

在预测期内，对具有成本效益的药物的需求不断增长以及政府对使用仿製药的支持预计将推动对用于吸入器和鼻喷雾剂的仿製药的需求。例如，日本政府提倡使用廉价的仿製药来调节总体药品支出。这是通过在过去十年中实施鼓励使用仿製药的法规来实现的。

Teva Pharmaceuticals、Glenmark Specialty SA 和 Hikma Pharmaceuticals PLC 等领先製造商之间增加的併购、合作伙伴关係和合作也是增长的主要驱动力之一。例如，2022 年 1 月，Glenmark Pharmaceuticals Ltd. 的瑞士子公司 Glenmark Specialty SA 将与 Lotus International Pte. Ltd. 合作，在越南、香港和新加坡销售 Lilatris 鼻喷雾剂。根据协议条款，Glenmark Specialty SA 将生产和供应 Lialtolis，由 Lotus International Pte 进行商业化。同样，2020 年 2 月，Glenmark Specialty 与 Higuma Pharmaceuticals PLC 就 ryaltoricin 在美国的商业化签订了许可协议。

製药公司在呼吸药物发现和吸入器和鼻喷雾剂的仿製药批准方面的广泛研究预计将推动增长。例如，2021 年 3 月，Cipla Inc. 获得了美国 FDA 对舒马曲坦鼻喷雾剂的 ANDA 批准，舒马曲坦鼻喷雾剂是 Imitrex 鼻喷雾剂的通用版本，用于治疗偏头痛。2020 年 5 月，随着 Migranal 仿製药 Dihydroergotamine Mesilate Nasal Drop 的 ANDA 批准，FDA 还授予了竞争性仿製药名称。

吸入器和鼻腔喷雾仿製药市场报告亮点

按药物类别划分，由于 COPD 和哮喘的高患病率，支气管扩张剂在 2021 年占据市场主导地位

由于仿製药的推出以及中低收入国家慢性阻塞性肺病（COPD）患病率的增加，预计慢性阻塞性肺病（COPD）适应症部分在预测期内增长最快。

根据患者人口统计，由于接触环境过敏原（如污染、吸烟和花粉）的增加，预计儿科患者在预测期内增长最快

慢性病患病率上升和患有慢性呼吸系统疾病的老年人口不断增加，推动家庭护理最终用户细分市场在 2021 年占据主导地位

由于处方成本低、互联网普及率提高和访问便利等消费者需求，预计在线药房分销渠道在预测期内增长最快。

2021年，北美主导市场。这是由于领先公司在该地区开发和推出仿製药的战略举措和合作伙伴关係。

目录

第一章 调查方法和范围

  • 市场细分
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 第一次调查的内容
    • 主要信息列表
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法一：商品流动方法
      • 方法 2：使用自下而上的方法进行国别市场估算
  • 全球市场：复合年增长率计算
  • 调查假设
  • 二级信息列表
  • 缩略语表
  • 目的

第二章执行摘要

  • 市场概况

第三章市场变量、趋势和范围

  • 市场系列展望
    • 母公司的市场前景
  • 监管框架
  • 绘製渗透率和增长前景
  • 管道分析
  • 市场动态
    • 市场驱动力分析
    • 市场约束分析
  • PESTEL 分析

4 2018-2030 年全球吸入器和鼻腔喷雾仿製药市场细分分析，按药物类别（百万美元）

  • 全球吸入和鼻腔喷雾仿製药市场：药物类别变化分析
  • 支气管扩张剂
  • 配合剂
  • 皮质类固醇
  • 减充血喷雾
  • 抗组胺药
  • 其他

5 全球吸入器和鼻腔喷雾仿製药市场细分分析，按适应症，2018-2030 年（百万美元）

  • 全球吸入和鼻腔喷雾仿製药市场：适应症变化分析
  • 哮喘
  • 慢性阻塞性肺病（COPD）
  • 过敏性鼻炎
  • 其他

第 6 章全球吸入器和鼻腔喷雾仿製药市场细分分析，患者人口统计，2018-2030 年（百万美元）

  • 全球吸入器和鼻腔喷雾仿製药市场：患者人口统计变化分析
  • 成年患者
  • 儿科病人
  • 老年患者

第 7 章全球吸入器和鼻腔喷雾仿製药市场细分分析，按最终用户，2018-2030 年（百万美元）

  • 全球吸入和鼻腔喷雾仿製药市场：最终用户变化分析
  • 医院
  • 癌症研究所
  • 其他

8 2018-2030 年按分销渠道分列的全球吸入器和鼻腔喷雾仿製药市场细分分析（百万美元）

  • 全球吸入器和鼻腔喷雾仿製药市场：分销渠道动态分析
  • 零售药店
  • 医院药房
  • 网上药店

9. 吸入器和鼻腔喷雾仿製药市场：细分分析，按地区，2018-2030 年（百万美元）

  • 吸入器和鼻喷雾仿製药市场：区域差异分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 意大利
      • 俄罗斯
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 澳大利亚
      • 韩国
      • 新加坡
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

10 全球吸入器和鼻腔喷雾仿製药市场：竞争分析

  • 主要市场参与者的最新发展和影响分析
    • 重大交易和战略联盟分析
      • 新产品发布
      • 併购
      • 伙伴关係和合同
  • 公司分类
    • 创新者
    • 市场领导者
    • 新兴玩家
    • 热图分析
  • 公司市场分析
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
    • 潜在最终用户列表
    • 2021 年主要参与者的市场份额分析
  • 2021年公司市场份额
    • 竞争仪錶盘分析
  • 民营企业
    • 主要初创企业名单
    • 区域网络图
  • 公司简介
    • Teva Pharmaceuticals
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Viatris Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Akorn, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Cipla Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Sandoz（Novartis AG）
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Apotex Inc.
      • 公司简介
      • 产品基准
      • 战略举措
    • Hikma Pharmaceuticals PLC
      • 公司简介
      • 财务绩效
      • 产品基准
    • Sun Pharma
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Beximco Pharmaceuticals Limited
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Nephron Pharma
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-965-9

Inhalation And Nasal Spray Generic Drugs Market Growth & Trends:

The global inhalation and nasal spray generic drugs market size is expected to reach USD 38.40 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.96% from 2022 to 2030. New product launches, mounting prevalence of chronic respiratory diseases, growing demand for cost-effective medicines, and rising geriatric population are some of the major factors boosting the market growth.

Rising demand for cost-effective medicines and government support for the use of generics is expected to drive the demand for inhalation and nasal spray generic drugs over the forecast period. For instance, the Government of Japan has been promoting the usage of inexpensive generic drugs in order to regulate the overall pharmaceutical expenditure. This was accomplished through the execution of regulations to encourage the use of generic drugs in the past decade.

Rising number of M&A, partnerships, and collaborations among leading manufacturers including Teva Pharmaceuticals, Glenmark Specialty S.A., and Hikma Pharmaceuticals PLC is another major factor propelling the growth. For instance, in January 2022, Glenmark Specialty S.A., a Swiss subsidiary of Glenmark Pharmaceuticals Ltd., partnered with Lotus International Pte. Ltd. for marketing Ryaltris nasal spray in Vietnam, Hong Kong, and Singapore. Under this agreement, Glenmark Specialty S.A. will manufacture and supply Ryaltris, and Lotus International Pte. Ltd. will commercialize the product. Similarly, in February 2020, Glenmark Specialty signed a licensing agreement with Hikma Pharmaceuticals PLC to commercialize Ryaltrisin in the U.S.

Extensive research in the respiratory drug discovery and generic product approvals of inhalation and nasal drugs by pharmaceutical companies are projected to fuel growth. For instance, in March 2021, Cipla Inc. received ANDA approval from the U.S. FDA for Sumatriptan Nasal Spray, a generic equivalent of Imitrex Nasal Spray indicated for migraine treatment. In addition, in May 2020, the company received Competitive Generic Therapy designation from FDA along with ANDA approval for Dihydroergotamine Mesylate Nasal Spray, a generic version of Migranal.

Inhalation And Nasal Spray Generic Drugs Market Report Highlights:

  • By drug class, bronchodilators dominated the market in 2021 owing to the high prevalence of COPD and asthma in the population
  • The chronic obstructive pulmonary disease (COPD) indication segment is expected to witness the fastest growth over the forecast period due to the launch of generic products and increased prevalence of COPD in low- and middle-income countries
  • Based on patient demographics, the pediatric patients segment is expected to witness the fastest growth over the forecast period due to an increase in pollution, smoking, and exposure to environmental allergens such as pollens
  • The homecare end-user segment dominated the market in 2021 owing to a rise in the prevalence of chronic diseases and rising geriatric population suffering from chronic respiratory diseases
  • The online pharmacies distribution channel segment is expected to witness the fastest growth over the forecast period due to consumer needs for low prescription costs, increased internet penetration, and ease of access
  • North America dominated the market in 2021 due to strategic initiatives and collaborations among key players for the development and launch of generic products in this region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation
    • 1.1.1 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR'S internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
    • 1.3.6 List of primary sources
  • 1.4 Information or data analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Abbreviations
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
    • 1.11.3 Objective 3
    • 1.11.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Regulatory framework
  • 3.3 Penetration and Growth Prospect Mapping
  • 3.4 Pipeline Analysis
  • 3.5 Market Dynamics
    • 3.5.1 Market driver analysis
    • 3.5.2 Market restraint analysis
  • 3.6 PESTEL Analysis

Chapter 4 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Drug Class, 2018 - 2030 (USD Million)

  • 4.1 Global Inhalation & Nasal Spray Generic Drugs Market: Drug Class Movement Analysis
  • 4.2 Bronchodilators
    • 4.2.1 Bronchodilators market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3 Combination Drugs
    • 4.3.1 Combination drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4 Corticosteroids
    • 4.4.1 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5 Decongestant Sprays
    • 4.5.1 Decongestant sprays market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6 Antihistamines
    • 4.6.1 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7 Others
    • 4.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, by Indication, 2018 - 2030 (USD Million)

  • 5.1 Global Inhalation & Nasal Spray Generic Drugs Market: Indication Movement Analysis
  • 5.2 Asthma
    • 5.2.1 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 5.3.1 Chronic obstructive pulmonary disease market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4 Allergic Rhinitis
    • 5.4.1 Allergic rhinitis market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5 Others
  • 5.5. 1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Patient Demographics, 2018 - 2030 (USD Million)

  • 6.1 Global Inhalation & Nasal Spray Generic Drugs Market: Patient Demographics Movement Analysis
  • 6.2 Adult Patient
    • 6.2.1 Adult patient market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Pediatric Patient
    • 6.3.1 Pediatric patient market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Geriatric Patient
    • 6.4.1 Geriatric patient market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By End-User, 2018 - 2030 (USD Million)

  • 7.1 Global Inhalation & Nasal Spray Generic Drugs Market: End-user Movement Analysis
  • 7.2 Hospitals
    • 7.2.1 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3 Cancer Institutes
    • 7.3.1 Cancer Institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4 Others
    • 7.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Global Inhalation & Nasal Spray Generic Drugs Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 8.1 Global Inhalation & Nasal Spray Generic Drugs Market: Distribution ChannelMovement Analysis
  • 8.2 Retail Pharmacies
    • 8.2.1 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3 Hospitals Pharmacies
    • 8.3.1 Hospitals pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Online Pharmacies
    • 8.4.1 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Inhalation & Nasal Spray Generic Drugs Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 9.1 Inhalation & Nasal Spray Generic Drugs Market: Regional Movement Analysis
    • 9.1.1 North America
      • 9.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.1.2 U.S.
      • 9.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.1.3 Canada
      • 9.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2 Europe
      • 9.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.2 U.K.
      • 9.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.3 Germany
      • 9.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.4 France
      • 9.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.5 Spain
      • 9.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.6 Italy
      • 9.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.7 Russia
      • 9.1.2.7.1 Russia market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3 Asia Pacific
      • 9.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.2 Japan
      • 9.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.3 China
      • 9.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.4 India
      • 9.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.5 Australia
      • 9.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.6 South Korea
      • 9.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.7 Singapore
      • 9.1.3.7.1 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.4 Latin America
      • 9.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.2 Brazil
      • 9.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.3 Mexico
      • 9.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.4 Argentina
      • 9.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.5 Middle East & Africa
      • 9.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.2 South Africa
      • 9.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.3 Saudi Arabia
      • 9.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.4 United Arab Emirates
      • 9.1.5.4.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 Global Inhalation & Nasal Spray Generic Drugs Market: Competitive Analysis

  • 10.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 10.1.1 Major deals & strategic alliances analysis
      • 10.1.1.1 New Product Launches
      • 10.1.1.2 Mergers and Acquisitions
      • 10.1.1.3 Partnerships & Agreements
  • 10.2 Company Categorization
    • 10.2.1 Innovators
    • 10.2.2 Market Leaders
    • 10.2.3 Emerging Players
    • 10.2.4 Heat Map Analysis
  • 10.3 Company Market Position Analysis
  • 10.4 Vendor Landscape
    • 10.4.1 List of Key Distributors and Channel Partners
    • 10.4.2 List of Potential End Users
    • 10.4.3 Key Company Market Share Analysis, 2021
  • 10.5 Company Market Share, 2021
    • 10.5.1 Competitive Dashboard Analysis
  • 10.6 Private Companies
    • 10.6.1 List of Key Emerging Companies
    • 10.6.2 Regional Network Map
  • 10.7 Company Profiles
    • 10.7.1 Teva Pharmaceuticals
      • 10.7.1.1 Company overview
      • 10.7.1.2 Financial performance
      • 10.7.1.3 Product benchmarking
      • 10.7.1.4 Strategic initiatives
    • 10.7.2 Viatris Inc.
      • 10.7.2.1 Company overview
      • 10.7.2.2 Financial performance
      • 10.7.2.3 Product benchmarking
      • 10.7.2.4 Strategic initiatives
    • 10.7.3 Akorn, Inc.
      • 10.7.3.1 Company overview
      • 10.7.3.2 Financial performance
      • 10.7.3.3 Product benchmarking
      • 10.7.3.4 Strategic initiatives
    • 10.7.4 Cipla Inc.
      • 10.7.4.1 Company overview
      • 10.7.4.2 Financial performance
      • 10.7.4.3 Product benchmarking
      • 10.7.4.4 Strategic initiatives
    • 10.7.5 Sandoz (Novartis AG)
      • 10.7.5.1 Company overview
      • 10.7.5.2 Financial performance
      • 10.7.5.3 Product benchmarking
      • 10.7.5.4 Strategic initiatives
    • 10.7.6 Apotex Inc.
      • 10.7.6.1 Company overview
      • 10.7.6.2 Product benchmarking
      • 10.7.6.3 Strategic initiatives
    • 10.7.7 Hikma Pharmaceuticals PLC
      • 10.7.7.1 Company overview
      • 10.7.7.2 Financial performance
      • 10.7.7.3 Product benchmarking
    • 10.7.8 Sun Pharma
      • 10.7.10.1 Company overview
      • 10.7.10.2 Financial performance
      • 10.7.10.3 Product benchmarking
      • 10.7.10.4 Strategic initiatives
    • 10.7.9 Beximco Pharmaceuticals Limited
      • 10.7.9.1 Company overview
      • 10.7.9.2 Financial performance
      • 10.7.9.3 Product benchmarking
      • 10.7.9.4 Strategic initiatives
    • 10.7.10 Nephron Pharma
      • 10.7.10.1 Company overview
      • 10.7.10.2 Financial performance
      • 10.7.10.3 Product benchmarking
      • 10.7.10.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Inhalation & Nasal Spray Generic Drugs Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 5 Global Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 6 Global Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 7 Global Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 8 Global Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 9 North America Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 North America Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 11 North America Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 12 North America Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 13 North America Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 14 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 15 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 17 U.S. Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 18 U.S. Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 19 Canada Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 20 Canada Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 21 Canada Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 22 Canada Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 23 Canada Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 24 Europe Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 Europe Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 26 Europe Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 27 Europe Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 28 Europe Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 29 Germany Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 Germany Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 31 Germany Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 32 Germany Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 33 Germany Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 34 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 35 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 36 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 37 U.K. Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 38 U.K. Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 39 France Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 40 France Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 41 France Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 42 France Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 43 France Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 44 Italy Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Italy Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 46 Italy Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 47 Italy Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 48 Italy Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 49 Spain Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Spain Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 51 Spain Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 52 Spain Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 53 Spain Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 54 Russia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Russia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 56 Russia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 57 Russia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 58 Russia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 64 Japan Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 65 Japan Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 66 Japan Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 67 Japan Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 68 Japan Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 69 China Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 China Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 71 China Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 72 China Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 73 China Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 74 India Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 75 India Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 76 India Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 77 India Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 78 India Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 79 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 80 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 81 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 82 South Korea Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 83 South Korea Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 84 Australia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 85 Australia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 86 Australia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 87 Australia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 88 Australia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 89 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 90 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 91 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 92 Singapore Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 93 Singapore Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 94 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 95 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 96 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 97 Latin America Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 98 Latin America Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 99 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 100 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 101 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 102 Brazil Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 103 Brazil Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 104 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 105 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 106 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 107 Mexico Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 108 Mexico Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 109 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 110 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 111 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 112 Argentina Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 113 Argentina Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 114 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 115 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 116 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 117 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 118 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 120 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 122 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 123 Saudi Arabia Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 124 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 125 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 126 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 127 South Africa Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 128 South Africa Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)
  • Table 129 UAE Inhalation & Nasal Spray Generic Drugs Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 130 UAE Inhalation & Nasal Spray Generic Drugs Market, By Indication, 2018 - 2030 (USD Million)
  • Table 131 UAE Inhalation & Nasal Spray Generic Drugs Market, By Patient Demographics, 2018 - 2030 (USD Million)
  • Table 132 UAE Inhalation & Nasal Spray Generic Drugs Market, By End-User, 2018 - 2030 (USD Million)
  • Table 133 UAE Inhalation & Nasal Spray Generic Drugs Market, By Distribution Channel 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Inhalation &nasal spray generic drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Inhalation &nasal spray generic drugs market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2021 (USD Million)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Inhalation &nasal spray generic drugs market driver impact
  • Fig. 14 Inhalation & nasal spray generic drugs market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Inhalation &nasal spray generic drugs market: Drug class outlook and key takeaways
  • Fig. 19 Inhalation &nasal spray generic drugs market: Drug class movement analysis & market share 2021 & 2030
  • Fig. 20 Bronchodilators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Combination market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Decongestant sprays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Inhalation &nasal spray generic drugs market: Indication outlook and key takeaways
  • Fig. 27 Inhalation &nasal spray generic drugs market: Indication movement analysis & market share 2021 & 2030
  • Fig. 28 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Allergic rhinitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Inhalation & nasal spray generic drugs market: Patient demographics outlook and key takeaways
  • Fig. 33 Inhalation & nasal spray generic drugs market: Patient demographics movement analysis & market share 2021 & 2030
  • Fig. 34 Adult patient market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Pediatric patient market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Geriatric patient market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Inhalation & nasal spray generic drugs market: End-user outlook and key takeaways
  • Fig. 38 Inhalation & nasal spray generic drugs market: End-user movement analysis & market share 2021 & 2030
  • Fig. 39 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Inhalation & nasal spray generic drugs market: Distribution channel outlook and key takeaways
  • Fig. 43 Inhalation & nasal spray generic drugs market: Distribution channel movement analysis & market share 2021 & 2030
  • Fig. 44 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Hospitals pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Inhalation & nasal spray generic drugs: Regional outlook and key takeaways
  • Fig. 48 Regional outlook, 2021 & 2030
  • Fig. 49 North America
  • Fig. 50 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 U.S.
  • Fig. 52 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Canada
  • Fig. 54 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Europe
  • Fig. 56 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 U.K.
  • Fig. 58 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Germany
  • Fig. 60 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 France
  • Fig. 62 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Italy
  • Fig. 64 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Spain
  • Fig. 66 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Russia
  • Fig. 68 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Japan
  • Fig. 72 Japan market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 73 China
  • Fig. 74 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 India
  • Fig. 76 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Australia
  • Fig. 80 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Singapore
  • Fig. 82 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America
  • Fig. 84 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Brazil
  • Fig. 86 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Mexico
  • Fig. 88 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina
  • Fig. 90 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Middle East & Africa
  • Fig. 92 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 South Africa
  • Fig. 94 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Saudi Arabia
  • Fig. 96 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 UAE
  • Fig. 98 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Market differentiators
  • Fig. 100 Key company market share analysis, 2021
  • Fig. 101 Company market position analysis
  • Fig. 102 Competitive dashboard analysis
  • Fig. 103 Regional network map